Resseptor Therapeutics

About:

Resseptor Therapeutics enhances the treatment of the immune system's ability to identify and respond to tissues, malignancies, and pathogens

Website: https://www.resseptor.com/

Top Investors: IP Group Australia

Description:

Total Funding Amount:

2.25M AUD

Headquarters Location:

Melbourne, Victoria, Australia

Founded Date:

2023-01-01

Contact Email:

info(AT)resseptor.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2023-06-06

IPO Status:

Private

Industries: